Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fosun Pharma Increases Stake In Chengde Jingfukang Pharma To 25 Percent

This article was originally published in PharmAsia News

Executive Summary

Shanghai Fosun Pharmaceutical Group and Chengde Jingfukang Pharmaceutical Group held an investment cooperation signing ceremony Mar. 28, during which Fosun Pharma agreed to increase investment in Jingfukang Pharma by RMB 120 million. After completion of the transaction, Fosun Pharma will hold a 25 percent stake in Jingfukang Pharma. For Fosun Pharma, the move represents a big leap into the TCM drug industry. (Click Here For More - Chinese Language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts